FDA Inspection 1113285 — FXM Clinical Research Miami LLC
The FDA completed an inspection of FXM Clinical Research Miami LLC on December 10, 2019 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 10, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional Details
Clinical BA/BE